Related items

How can Europe strengthen its digital resilience while remaining open to the partnerships that drive AI innovation? On Wednesday, 17 June, Malte Lohan, CEO, AmCham EU, addressed this at a conference organised by the Cypriot Presidency of the Council of the EU in Nicosia, Cyprus. Discussions focused on how Europe can build a more resilient digital ecosystem while remaining an attractive destination for investment and innovation. Mr Lohan underlined that secure supply chains and trusted partnerships are essential to Europe’s AI competitiveness. He also highlighted the role of US businesses as committed partners in helping Europe build and compete globally, while stressing the need for balanced policies that strengthen resilience and give companies the confidence to invest in Europe.

Authored by Malte Lohan, CEO, AmCham EU

Europe’s life sciences sector sits at the heart of the EU’s competitiveness agenda. It supports advanced manufacturing and helps bring new treatments and technologies to patients. Yet companies deciding where to invest need a regulatory environment that is predictable and open to global cooperation. 

The European Commission’s work on the Biotech Act and the targeted revision of the Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) offers an opportunity to improve that environment. Both files can help make Europe a stronger location for life sciences investment. 

The EU should use this moment to build a framework that keeps pace with scientific progress. That means faster and clearer procedures. It also means better use of data and intellectual property rules that recognise the realities of global supply chains.